An expanded cannabinoids delivery patent boosted a Canadian cannabis stock Wednesday. Here’s some small stocks making big moves on Wednesday, April 17, 2019 (as of 4 pm EST):
Revive Therapeutics Ltd. (TSXV:RVV), a Canadian cannabis stock, rose 13% to $0.17 on Wednesday after announcing that it has been granted United States Patent No. 10,104,888, titled “Tannin-chitosan composites,” by the United States Patent and Trademark Office, which expands Revive’s coverage for the delivery of cannabinoids in various delivery routes.
As well, shares of Millennial Lithium Corp. (TSXV:ML) climbed 17% to $1.89 as the lithium junior said it has released an updated lithium and potassium resource statement for its Pastos Grandes brine project in Argentina, which shows 4,120,000 tonnes of lithium carbonate equivalent, a nearly 100% increase from its 2017 estimate.
Fintech Select Ltd. (TSXV:FTEC), meanwhile, reported a fiscal 2018 net profit of $765,000 as well as a $1.9 million reduction in its liability. Fintech Select stock moved up 29% to $0.045 following the announcement.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
Revive Therapeutics Ltd. (TSXV:RVV), a Canadian cannabis stock, rose 13% to $0.17 on Wednesday after announcing that it has been granted United States Patent No. 10,104,888, titled “Tannin-chitosan composites,” by the United States Patent and Trademark Office, which expands Revive’s coverage for the delivery of cannabinoids in various delivery routes.
